Apply
Pour granules to cover the entire wound bed, then drip saline to accelerate hydration.
A scientifically engineered transforming powder dressing that hydrates into a flexible, oxygen-permeable matrix directly on the wound bed. One product. Any geometry. Extended wear time, typically applied for 7 days and worn longer.
A short demonstration of the powder-to-matrix transformation, applied directly on the wound bed.
Altrazeal is a methacrylate-based, transforming powder dressing engineered to cover and protect the wound and provide an ideal moist healing environment that supports cellular function and tissue repair.
Its non-resorbable, sterile granules aggregate on contact with saline to form a moist, flexible, oxygen-permeable film that fits and seals the wound. The result is a skin-like barrier that promotes healthy granulation tissue growth.
Six stages, from dry granules to flake-off, driven by a patented methacrylate-based chemistry that transforms with a simple saline drip.
Pour granules to cover the entire wound bed, then drip saline to accelerate hydration.
On contact with moisture, the granules self-aggregate into a conformable matrix.
The matrix forms an oxygen-permeable dressing that manages exudate through vapor transpiration.
The dressing fits and seals the wound as a flexible, skin-like barrier.
Bacteria are too large to penetrate, preventing microbial migration into the wound.
As the wound heals, the dressing loses hydration at the margin and gradually flakes off.
Altrazeal works best on clean wounds with mild to moderate exudation, across surgical, acute, and chronic indications.
Synergistic with other modalities: NPWT transition dressing · Total contact cast · Compression bandage · Hyperbaric oxygen therapy.
Published comparison of Altrazeal against leading wound care modalities.
| Property | Altrazeal | Hydrogel | Foams | Hydrocolloid | Hydrofiber | Alginate |
|---|---|---|---|---|---|---|
| No adhesive required | ✓ | × | × | Sometimes | × | × |
| No secondary dressing | ✓most cases | × | ✓ | ✓ | × | × |
| Fills & seals the wound | ✓ | × | × | × | × | × |
| Intimate wound contact | ✓ | × | × | × | ✓ | Moderate |
| Barrier to microorganisms | ✓ | × | Mixed | Mixed | × | × |
| Remains flexible over joints | ✓ | × | × | × | – | – |
| Dressing change frequency | 1 / week or less | 3–4 / week | 3–4 / week | 3–4 / week | 2–4 / week | 2–4 / week |
Altrazeal is truly a revolutionary technology that will change the way we think about wound dressings. Clinical experience has demonstrated excellent outcomes with improved wound healing trajectories in a wide variety of wound types.
Transforms into a flexible dressing that fits the exact geometry of the wound bed.
Extended wear time lets wounds heal undisturbed, reducing cost of care and nursing time.
Oxygen enters the wound environment, supporting cellular function and repair.
Absorbs approximately 68% water of its hydrated mass and controls fluid through vapor transpiration.
Prevents exogenous bacteria from entering the wound, while remaining breathable.
Saturate with saline and lift off. No pain, no trauma, no skin stripping.
A selection of published clinical outcomes, from surgical wounds to chronic ulcers that had resisted conventional treatment for years.
Patients reached closure in 14 days with Altrazeal versus a standard 35 days, a significantly steeper healing trajectory reported across a range of wounds.
Multi-wound study93-year-old female with four venous ulcers unhealed for eight years under conventional dressings. All four fully healed in 63 days on Altrazeal with compression therapy.
Venous Ulcer · CompressionCaesarean-section wound sealed with a single Altrazeal application for eight days. Patient reported reduced pain and the wound remained free of infection throughout.
Surgical · C-Section70-year-old female with a painful non-healing malleolus wound, worsening despite debridement and IV antibiotics. Wound closed on day 84 with Altrazeal. Amputation avoided.
Arterial Ulcer
Altrazeal is produced at Arabian House Industries' cleanroom facility in Riyadh, a Saudi-made medical device delivered to hospitals across the Kingdom and the GCC.
Officially Certified Saudi Made Program Conferences and clinical engagements where AHI introduced Altrazeal to the wound care community across the Kingdom and the region.
2026 1 photo AHI showcased Altrazeal at the Riyadh International Conference for Wound Care, engaging with wound care specialists from across the Kingdom and the region.
2024 2 photos Altrazeal featured at the regional vascular conference, including a clinical abstract on its role in managing complex vascular wounds.
2024 1 photo AHI participated in the Jeddah diabetic foot conference, presenting Altrazeal to clinicians treating chronic and complex foot wounds.
2023 1 photo Altrazeal at the international diabetic foot conference in Riyadh, engaging with specialists from across the region on advanced wound care.
Talk to AHI about availability, clinical training, and distribution across the Kingdom and the wider GCC.